Restless legs syndrome (RLS) is strikingly common in CKD and dialysis patients. The irresistible urge to move, the iron connection, and treatments that actually help.
Evidence reviewed & updated: 2026-08 — reflects the latest published trials and guidelines.
Restless legs syndrome affects up to 20-25% of dialysis patients — several times the general population rate. The mechanism is closely tied to the iron deficiency that kidney failure creates, plus uremic nerve irritation. Treatment is highly effective when directed at the right cause: iron repletion first, then gabapentinoids or dopamine agents.
The clearest mechanism in kidney disease: RLS is driven by brain iron deficiency, and CKD patients are iron-starved — from blood loss, poor absorption, and hepcidin trapping iron in storage. Restless legs is one of the most treatable complications of the iron deficiency that dialysis care already tracks.
RLS prevalence in dialysis is 2-3× the general population — and it's associated with worse sleep, depression, and even higher mortality in some cohorts. It's a real complication, not a quirk.
Step 1: iron. Measure ferritin and transferrin saturation; in dialysis patients this usually means IV iron to get transferrin saturation to target — and RLS frequently improves as iron repletes. Step 2: medications — gabapentin or pregabalin at renal-adjusted doses are now favored first-line (effective, fewer side effects); dopamine agonists (ropinirole, pramipexole) are an alternative but carry augmentation risk with long-term use.
Step 3: trim the aggravators — caffeine and alcohol in the evening, and medications that worsen RLS (some antihistamines, SSRIs, antipsychotics). Dialysis timing and adequacy also play a role; some patients feel symptoms most on dialysis days.
One question finds most cases: 'When you sit or lie down to rest, do you get an urge to move your legs that's hard to resist?' If yes — with worsening at night and relief with movement — the RLS diagnosis is essentially clinical. The tragedy is how often it's never asked; the treatment gap is large and treatable.
Chronic itching affects roughly 40-70% of dialysis patients — and it's one of the most under-treated symptoms in kidney ...
Learn moreMost dialysis patients sleep poorly — insomnia, sleep apnea, and restless legs all run far above population rates. The r...
Learn morePost-dialysis fatigue affects a large share of dialysis patients — exhaustion lasting hours to a day after treatment. It...
Learn moreDepression is the most common complication nobody screens for: it affects roughly a third of dialysis patients — higher ...
Learn moreZuvFlo is ready to integrate with your facility to streamline operations, automate compliance, and deliver better patient care.
No credit card required • Setup in under 2 hours • Cancel anytime
Advertisement